Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
Bicalutamide
Juno Pharmaceuticals Pty Ltd
Bicalutamide
_Bicalutamide AN tablets – Consumer Medicine Information _ _ _ _Bicalutamide AN CMI v2.0 _ _ _ _ _ _Page 1 _ BICALUTAMIDE AN TABLETS _Bicalutamide _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions people ask about BICALUTAMIDE AN. It does not contain all the information that is known about BICALUTAMIDE AN. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor will have weighed the risks of you taking BICALUTAMIDE AN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BICALUTAMIDE AN IS USED FOR BICALUTAMIDE AN is used in combination with other medicines to treat advanced prostate cancer. BICALUTAMIDE AN is an antiandrogen medicine. Androgens such as testosterone are natural male sex hormones. In some types of prostate cancer, androgens may help the cancer cells to grow. BICALUTAMIDE AN interferes with some of the actions of these hormones. BICALUTAMIDE AN should only be taken by men. FOLLOW ALL DIRECTIONS GIVEN TO YOU BY YOUR DOCTOR. They may differ from the information in this leaflet. Your doctor may prescribe this medicine for another use. Ask your doctor if you want more information. BICALUTAMIDE AN is not addictive. BEFORE YOU TAKE BICALUTAMIDE AN _WHEN YOU MUST NOT USE IT _ DO NOT TAKE BICALUTAMIDE AN IF YOU ARE A WOMAN. Women are not normally treated with BICALUTAMIDE AN. DO NOT GIVE BICALUTAMIDE AN TO CHILDREN. There is no experience of its use in children. DO NOT TAKE BICALUTAMIDE AN IF YOU ARE ALLERGIC TO BICALUTAMIDE OR ANY OF THE OTHER INGREDIENTS IN BICALUTAMIDE AN. DO NOT TAKE BICALUTAMIDE AN IF YOU ARE TAKING CISAPRIDE OR THE ANTIHISTAMINES, TERFENADINE AND ASTEMIZOLE. DO NOT TAKE BICALUTAMIDE AN AFTER THE USE BY (EXPIRY) DATE PRINTED ON THE PACK. It may have no effect at all or an unexpected effect if you take it after Přečtěte si celý dokument
_Bicalutamide AN tablets Product Information _ _ _ _Amneal Pharma Australia Pty Ltd _ Bicalutamide AN PI v 2.0 Page 1 BICALUTAMIDE AN _(BICALUTAMIDE 50MG TABLETS) _ PRODUCT INFORMATION NAME OF THE MEDICINE The name of this medicine is Bicalutamide. CHEMICAL NAME: (_RS_)-4'-Cyano-α’, α’, α’,-trifluoro-3-(4-fluorophenylsulfonyl)-2-hydroxy-2- methylpropiono-_m_-toluidide MOLECULAR FORMULA: C 18 H 14 F 4 N 2 O 4 S MOLECULAR WEIGHT: 430.38 g/mol CAS REGISTRY NUMBER: 90357-06-5 DESCRIPTION Bicalutamide is a fine white to off-white powder. At 37 o C it is practically insoluble in water (4.6 mg/litre), acid (4.6 mg/litre at pH 1) and alkali (3.7 mg/litre at pH 8). In organic solvents it is slightly soluble in ethanol, sparingly soluble in methanol and freely soluble in acetone and tetrahydrofuran. Bicalutamide AN tablets are white film-coated tablets containing 50 mg bicalutamide. Each tablet contains the following excipients: lactose, sodium starch glycollate type A, povidone, magnesium stearate, hypromellose, macrogol 400 and titanium dioxide. PHARMACOLOGY Bicalutamide is a non-steroidal anti-androgen, devoid of other endocrine activity. It binds to androgen receptors without activating gene expression, and thus inhibits the androgen stimulus. This inhibition impairs the growth and encourages apoptosis in androgen- dependent tumour cells and regression of prostatic tumours. In a subset of patients who experience disease progression while receiving bicalutamide, discontinuation of the medicine may result in an ‘anti-androgen withdrawal syndrome’, which manifests as a fall in prostate specific antigen (PSA) level. It is unknown whether this phenomenon translates to a prolongation of tumour response or survival. _Bicalutamide AN tablets Product Information _ _ _ _Amneal Pharma Australia Pty Ltd _ Bicalutamide AN PI v 2.0 Page 2 Bicalutamide is a racemate with its antiandrogenic activity being almost exclusively in the (R)- enantiomer. PHARMACOKINETICS _Absorption_ Bicalutamide is well absorbed following oral Přečtěte si celý dokument